J9017 Arsenic trioxide injection
Also known as: Trisenox, Arsenic trioxide
Arsenic trioxide administered by injection; used for acute promyelocytic leukemia treatment.
In Plain Language
Acute promyelocytic leukemia treatment injection; Arsenic chemotherapy
Clinical Context
Used for acute promyelocytic leukemia with APL fusion gene. Induces apoptosis and differentiation of leukemic cells.
RVU Information
CPT J9017 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9017?
CPT J9017 (Arsenic trioxide injection) is a J Codes (Drugs) code. Arsenic trioxide administered by injection; used for acute promyelocytic leukemia treatment.
How is J9017 administered?
CPT J9017 is administered by a healthcare provider, typically via injection or infusion. Used for acute promyelocytic leukemia with APL fusion gene. Induces apoptosis and differentiation of leukemic cells. It is used by Oncology, Hematology, Internal Medicine.
When is CPT J9017 used?
Used for acute promyelocytic leukemia with APL fusion gene. Induces apoptosis and differentiation of leukemic cells.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.